Literature DB >> 23740274

Epidemiology and outcome of thrombocytopenic patients in the intensive care unit: results of a prospective multicenter study.

Fabrice Thiolliere1, Anne Françoise Serre-Sapin, Jean Reignier, Marcel Benedit, Jean Michel Constantin, Christine Lebert, Dominique Guélon, Jean François Timsit, Bertrand Souweine.   

Abstract

PURPOSE: To assess the epidemiology of intensive care unit (ICU) patients with thrombocytopenia (TP).
METHODS: All consecutive ICU-admitted patients with TP either on admission or acquired during ICU stay were included. TP was defined as either absolute (platelet count <100 × 10(9)/L) or relative (decrease in the platelet count >30 %). Extensive diagnostic workup of TP including bone marrow aspiration was performed.
RESULTS: Absolute TP was diagnosed in 208 patients and relative TP in 93. In six patients (2 %), no cause of TP was identified. The median number of TP etiologies per patient was two, with sepsis being the leading cause. Bone marrow aspirates were analyzed in 238 patients. They showed a normal megakaryocyte number in 221 (93 %) and provided novel information for diagnosis in 52 (22 %). Results were susceptible to having an impact on patient management in 22 cases (11 %). The frequency of bone marrow aspiration with results susceptible to having an impact on management did not differ between patients with and without disseminated intravascular coagulation (P = 0.22) and with and without sepsis/septic shock (P = 0.7) but was significantly lower in patients with relative TP than in those with absolute TP (P < 0.01). A serious bleeding event was observed in 30 patients (14.9 %) and a nadir platelet count below 50 × 10(9)/L was an independent risk factor (P < 0.05).
CONCLUSIONS: In thrombocytopenic patients, sepsis is the leading cause of TP. Bone marrow aspirates may yield significant information on TP mechanisms and contribute to the subsequent management of patients, especially those with absolute TP.

Entities:  

Mesh:

Year:  2013        PMID: 23740274     DOI: 10.1007/s00134-013-2963-3

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  40 in total

1.  Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation.

Authors:  F B Taylor; C H Toh; W K Hoots; H Wada; M Levi
Journal:  Thromb Haemost       Date:  2001-11       Impact factor: 5.249

Review 2.  Hemophagocytic lymphohistiocytosis.

Authors:  G E Janka
Journal:  Hematology       Date:  2005       Impact factor: 2.269

3.  Impact of thrombocytopenia on outcome of patients admitted to ICU for severe community-acquired pneumonia.

Authors:  Nicolas Brogly; Patrick Devos; Nicolas Boussekey; Hugues Georges; Arnaud Chiche; Olivier Leroy
Journal:  J Infect       Date:  2007-03-09       Impact factor: 6.072

4.  Modified score for disseminated intravascular coagulation in the critically ill.

Authors:  Mirka Sivula; Minna Tallgren; Ville Pettilä
Journal:  Intensive Care Med       Date:  2005-06-15       Impact factor: 17.440

5.  Thrombocytopenia in a surgical ICU.

Authors:  F Stéphan; J Hollande; O Richard; A Cheffi; M Maier-Redelsperger; A Flahault
Journal:  Chest       Date:  1999-05       Impact factor: 9.410

6.  Thrombocytopenia in medical-surgical critically ill patients: prevalence, incidence, and risk factors.

Authors:  Mark A Crowther; Deborah J Cook; Maureen O Meade; Lauren E Griffith; Gordon H Guyatt; Donald M Arnold; Christian G Rabbat; William H Geerts; Theodore E Warkentin
Journal:  J Crit Care       Date:  2005-12       Impact factor: 3.425

7.  Time course of platelet counts in critically ill patients.

Authors:  Serdar Akca; Philip Haji-Michael; Arnaldo de Mendonça; Peter Suter; Marcel Levi; Jean Louis Vincent
Journal:  Crit Care Med       Date:  2002-04       Impact factor: 7.598

8.  Predictors of short and long-term outcome in patients with hematological disorders admitted to the intensive care unit for a life-threatening complication.

Authors:  Honar Cherif; Claes-Roland Martling; Jan Hansen; Mats Kalin; Magnus Björkholm
Journal:  Support Care Cancer       Date:  2007-05-22       Impact factor: 3.603

9.  Potential risk factors associated with thrombocytopenia in a surgical intensive care unit.

Authors:  M J Cawley; E T Wittbrodt; E G Boyce; D J Skaar
Journal:  Pharmacotherapy       Date:  1999-01       Impact factor: 4.705

Review 10.  Platelets in defense against bacterial pathogens.

Authors:  Michael R Yeaman
Journal:  Cell Mol Life Sci       Date:  2009-12-15       Impact factor: 9.261

View more
  28 in total

1.  Highlighting the important effect of systemic lupus erythematosus on platelet count of critically ill patients.

Authors:  Otavio T Ranzani; Fernando G Zampieri; Marcelo Park
Journal:  Intensive Care Med       Date:  2013-07-17       Impact factor: 17.440

2.  Thrombocytopenia in the critically ill: considering pathophysiology rather than looking for a magic threshold.

Authors:  Frédéric Pène; Dominique D Benoit
Journal:  Intensive Care Med       Date:  2013-07-24       Impact factor: 17.440

3.  Year in review in Intensive Care Medicine 2013: II. Sedation, invasive and noninvasive ventilation, airways, ARDS, ECMO, family satisfaction, end-of-life care, organ donation, informed consent, safety, hematological issues in critically ill patients.

Authors:  Elie Azoulay; Giuseppe Citerio; Jan Bakker; Matteo Bassetti; Dominique Benoit; Maurizio Cecconi; J Randall Curtis; Glenn Hernandez; Margaret Herridge; Samir Jaber; Michael Joannidis; Laurent Papazian; Mark Peters; Pierre Singer; Martin Smith; Marcio Soares; Antoni Torres; Antoine Vieillard-Baron; Jean-François Timsit
Journal:  Intensive Care Med       Date:  2014-01-24       Impact factor: 17.440

4.  Prophylactic Platelet Transfusions for Critically Ill Patients With Thrombocytopenia: A Single-Institution Propensity-Matched Cohort Study.

Authors:  Matthew A Warner; Arun Chandran; Ryan D Frank; Daryl J Kor
Journal:  Anesth Analg       Date:  2019-02       Impact factor: 5.108

Review 5.  [Coagulation disorders in the intensive care station].

Authors:  C Hart; M Spannagl
Journal:  Internist (Berl)       Date:  2014-05       Impact factor: 0.743

6.  Platelet transfusions in cancer patients with hypoproliferative thrombocytopenia in the intensive care unit.

Authors:  Bassem Habr; Julien Charpentier; Benoît Champigneulle; Agnès Dechartres; Fabrice Daviaud; Guillaume Geri; Alain Cariou; Jean-Daniel Chiche; Jean-Paul Mira; Frédéric Pène
Journal:  Ann Intensive Care       Date:  2015-12-01       Impact factor: 6.925

7.  The potential of antimicrobials to induce thrombocytopenia in critically ill patients: data from a randomized controlled trial.

Authors:  Maria Egede Johansen; Jens-Ulrik Jensen; Morten Heiberg Bestle; Lars Hein; Anne Øberg Lauritsen; Hamid Tousi; Kim Michael Larsen; Jesper Løken; Thomas Mohr; Katrin Thormar; Pär I Johansson; Alessandro Cozzi-Lepri; Jens D Lundgren
Journal:  PLoS One       Date:  2013-11-28       Impact factor: 3.240

8.  The role of whole blood impedance aggregometry and its utilisation in the diagnosis and prognosis of patients with systemic inflammatory response syndrome and sepsis in acute critical illness.

Authors:  Gareth R Davies; Gavin M Mills; Matthew Lawrence; Ceri Battle; Keith Morris; Karl Hawkins; Phylip Rhodri Williams; Simon Davidson; Dafydd Thomas; Phillip Adrian Evans
Journal:  PLoS One       Date:  2014-09-30       Impact factor: 3.240

9.  Mechanisms and etiologies of thrombocytopenia in the intensive care unit: impact of extensive investigations.

Authors:  Nadiejda Antier; Jean-Pierre Quenot; Jean-Marc Doise; Robin Noel; Emmanuel Demaistre; Hervé Devilliers
Journal:  Ann Intensive Care       Date:  2014-08-02       Impact factor: 6.925

10.  Risks of bleeding and thrombosis in intensive care unit patients with haematological malignancies.

Authors:  Lene Russell; Lars Broksø Holst; Lars Kjeldsen; Jakob Stensballe; Anders Perner
Journal:  Ann Intensive Care       Date:  2017-12-11       Impact factor: 6.925

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.